drugset / Trial / NCT07253246
ENX-205 SAD/PET Study in Healthy Adults
RandomizedParallel-groupTriple-blindOther
Summary
This is a two-part study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and receptor occupancy (RO) of ENX-205 in healthy adult participants in a double-blind placebo-controlled, single ascending dose (SAD) study (Part 1) and an open-label, single-dose, positron emission tomography (PET) study (Part 2).
Timeline
- Start
- 2025-03-23
- Primary completion
- 2026-05-07
- Completion
- 2026-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ENX-205 | Unknown | — | Oral |
Indications
No indication recorded.